← Browse by Condition
Medical Condition

cardio vascular disease

Total Trials
4
Recruiting Now
4
Trial Phases
Phase 1

ClinicalMetric tracks all active clinical trials for cardio vascular disease sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — cardio vascular disease Clinical Trials

How many clinical trials are currently recruiting for cardio vascular disease?
ClinicalMetric currently tracks 4 actively recruiting clinical trials for cardio vascular disease, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 4. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for cardio vascular disease?
cardio vascular disease research spans Phase 1 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a cardio vascular disease clinical trial?
Eligibility criteria for cardio vascular disease trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1
1
Top Sponsors
Chang Gung University of Science and Technology 1 trial
University of Sao Paulo 1 trial
Chinese University of Hong Kong 1 trial
Dr. B. Catharine. Craven 1 trial

Recruiting Clinical Trials

NCT07310849
Recruiting
Digital Care for Holistic Health in Older Adults With Diabetes and Multimorbidity
Enrollment
169 pts
Location
Taiwan
Sponsor
Chang Gung University of Scien...
View Trial →
NCT07774845
Recruiting
Platelets and Plasma Lipids Relationship as a Biomarker and Potential Therapeutic Target of Thrombogenesis
Enrollment
45 pts
Location
Brazil
Sponsor
University of Sao Paulo
View Trial →
NCT07311941
Recruiting
Rapid Escalation of LipiD Lowering Therapy to Reduce RecUrrent Cardiovascular Event
Enrollment
1,000 pts
Location
Hong Kong
Sponsor
Chinese University of Hong Kon...
View Trial →
NCT07588503 Phase 1
Recruiting
FES Cycling With BFR in the Spinal Cord Injury Population
Enrollment
6 pts
Location
Canada
Sponsor
Dr. B. Catharine. Craven
View Trial →

Related Conditions

type2diabetes (1) hypertension (1) dyslipidemia (1) ckd (1) gout arthritis (1) hyperlipidemia (1) spinal cord injury (1) metabolic diseases type 2 diabetes cardiovascular disease (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology